REHMANN CAPITAL ADVISORY GROUP Edwards Lifesciences Corporation Transaction History

REHMANN CAPITAL ADVISORY GROUP portfolio value:

$804,898
portfolio value

REHMANN CAPITAL ADVISORY GROUP quarter portfolio value change:

-13.10%
quarter

Edwards Lifesciences Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +1.10% 106 shares -111.29K $82.63 9.74K
Q2 2022 share Increase +6.22% 564 shares -151.64K $95.09 9.63K
Q1 2022 share Increase +0.51% 46 shares -101.35K $117.72 9.07K
Q4 2021 share Decrease -8.76% -867 shares 49.31K $130.68 9.02K
Q3 2021 share Decrease -1.50% -151 shares 79.72K $113.21 9.89K
Q2 2021 share Increase +0.90% 90 shares 207.68K $103.57 10.04K
Q1 2021 share Increase +2.52% 245 shares -53.19K $83.64 9.95K
Q4 2020 share Decrease -0.37% -36 shares 107.89K $91.23 9.70K
Q3 2020 share Increase +0.17% 17 shares 105.53K $79.82 9.74K
Q2 2020 share Increase +2.28% 217 shares 74.30K $69.11 9.72K
Q1 2020 share Increase +3.70% 339 shares -74.33K $62.87 9.51K
Q3 2019 share Decrease -0.55% -51 shares 104.37K $73.3 9.17K
Q2 2019 share Decrease -0.58% -54 shares -23.70K $61.58 9.22K
Q1 2019 share Increase +0.52% 48 shares 120.44K $63.78 9.27K
Q4 2018 share Increase +0.20% 18 shares -63.33K $51.06 9.22K
Q3 2018 share Increase +0.16% 15 shares 88.31K $58.03 9.21K
Q2 2018 share Decrease -1.03% -96 shares 14.17K $48.52 9.19K
Q1 2018 share 0.00% 0 shares 83K $46.51 9.29K
Q4 2017 share Increase +3.27% 294 shares 21K $37.57 9.29K
Q3 2017 share Increase +34.91% 2.32K shares 65K $36.44 8.99K
Q2 2017 share Decrease -34.48% -3.51K shares -56K $39.41 6.66K
Q1 2017 share Increase +1.65% 165 shares 6K $31.36 10.17K
Q4 2016 share Increase +15.02% 1.30K shares -37K $31.23 10.01K
Q3 2016 share Increase +11.92% 927 shares 91K $40.19 8.70K
Q2 2016 share Decrease -3.25% -261 shares 23K $33.24 7.77K
Q1 2016 share Decrease -4.56% -384 shares 14K $29.4 8.04K